PAR
Click for more information
13.7% 29.0¢ paradigm biopharmaceuticals limited..

My wife has just applied to the knee study. If she qualifies...

  1. adherent
    200 Posts.
    lightbulb Created with Sketch. 383
    clock Created with Sketch.
    23/02/23
    18:45
    Post #: 66428979
    My wife has just applied to the knee study. If she qualifies that would make three pentosan patients in our household.
    PAR Price at posting: $1.36 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
0.035(13.7%) 		Mkt cap ! $101.4M
Open High Low Value Volume
25.5¢ 29.0¢ 25.0¢ $162.3K 595.5K

Buyers (Bids)

No. Vol. Price($)
2 49897 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 24504 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.